Abstract:OBJECTIVE:To evaluate the possibility and efficiency of nanoparticle as a new vector in vascular endothelial growth factor (VEGF) gene transference, and investigate the efficacy of direct gene transfer of nanoparticle with VEGF(165) gene into ischemic myocardium.METHODS:Nanoparticle-VEGF (Np/VEGF) complex was prepared with poly (D, L-lactide-co-glycolide) (PLGA) loading VEGF(165) gene and the envelopment efficiency and size of the complex were determined. The Np/VEGF was transfected into the cultured myocardial cells, RT-PCR and ELISA were used to evaluate the transfection of VEGF. Suspension of Np/VEGF was injected into the myocardial tissue of 4 rabbits. 96 hours after operation myocardial tissue was obtained, made into sections, and observed with electron microscope. New Zealand White rabbits underwent thoracotomy followed by ligation of left anterior descending coronary artery to establish ischemic models. The New Zealand White rabbits were divided into 3 groups: Np/VEGF group (n = 12, nanoparticle with VEGF(165) were injected into the cordial myocardium), blank plasmid group (n = 12, injected with blank VEGF(165) plasmid), and control group (n = 8, injected with normal saline). Ultrasonography and immunohistochemistry with factor VIII related antigen were conducted to evaluate the cardiac function and the collateral circulation of the occluded artery. One month later the rabbits were killed to observe the vascularization of capillaries in the ischemic myocardium.RESULTS:The envelopment efficiency of the Np/VEGF complex thus prepared, 50 - 300 nm in size, were 1.87% y. RT-PCR and ELISA showed that VEGF gene had been successfully transfected into myocardial cells by the nanoparticles. A great number of nanoparticles were observed in the myocardial cytoplasm and nuclei. One month after operation, the ventricular wall motor amplitude of the Np/VEGF group was 1.87 mm +/- 0.32 mm, significantly larger than those of the blank plasmid group (1.59 mm +/- 0.24 mm, P < 0.05) and control group (0.93 mm +/- 0.40 mm, P < 0.05); and the left ventricular ejection fraction of the Np/VEGF group was 60% +/- 10%, significantly higher than those of the blank plasmid group (50% +/- 6%, P < 0.05) and control group (40% +/- 8%, P < 0.05). The capillary density at low power field (x 100) of the Np/VEGF group was 57 +/- 12, significantly higher than those of the VEGF group (41 +/- 14) and control group (24 +/- 8).CONCLUSION:Nanoparticle can act as a vector to transfect specific gene in vitro and in vivo. Direct gene transfer of nanoparticle with DNA encoding VEGF into the ischemic rabbit myocardium can increase capillary number; therefore it may be a novel therapeutic approach for myocardial ischemia.

Retroviral vector mediated vascular endothelial growth factor gene therapy for experimental rabbits with cerebral ischemia

[Expression of Human VEGF165 Gene in Rat Bone Marrow Stromal Cells in Vitro].

[Effect of VEGF Gene Transfer on the Bleomycin-Induced Pulmonary Hypertension in Immature Rabbits].

Experimental Research on the Effect of VEGF on Angiogenesis in Focal Cerebral Ischemia

[Adenovirus-Mediated Vascular Endothelial Growth Factor165 Gene Therapy in Treatment of Hypoxic-Ischemic Brain Damage: Experiment with Rats].

Raav-Mediated VEGF Gene Transfer Induces Neovascular Formation in a Rabbit Myocardial Ischemic Model

[Effect of Nanoparticle with Vascular Endothelial Growth Factor Gene Transferred into Ischemic Myocardium: Experiment with Rabbits].

Angiogenesis Effect on Rat Liver after Administration of Expression Vector Encoding Vascular Endothelial Growth Factor D

A Small Interfering RNA Targeting Vascular Endothelial Growth Factor Efficiently Inhibits Growth of VX2 Cells and VX2 Tumor Model of Hepatocellular Carcinoma in Rabbit by Transarterial Embolization-Mediated Sirna Delivery.

Gene therapy with human vascular endothelial growth factor in prevention of restenosis after angioplasty

Direct Gene Transfer of Naked DNA Encoding Vascular Endothelial Growth Factor into Ischemic Rat Myocardium

Transfection of VEGF Gene in Rabbit Mesenchymal Stem Cells and Its Expression

Recombinant adeno-associated viral vector encoding human VEGF165 induces neomicrovessel formation in the adult mouse brain.

NO upgrades expression of VEGF protein and mRNA in local ischemic brain tissues of rabbits

Adenoviral Vector-Mediated Transduction of Vegf Improves Neural Functional Recovery after Hypoxia-Ischemic Brain Damage in Neonatal Rats

Inhibitory effects of local transfection of vascular endothelial growth factor 165 gene on intimal hyperplasia of artery in rabbits after operation injury

[The in Vivo and in Vitro Effects on Neovascularization of VEGF Gene Transfer with a New Pseudotyped Raav1 Vector].

Bone Marrow Mesenchymal Stem Cell Transplantation Combined with Vascular Endothelial Growth Factor 165 Gene Transfection Improved Heart Function After Myocardial Infarction in Rabbits

Adeno-associated Viral Vector-Mediated Hypoxia-Regulated VEGF Gene Transfer Promotes Angiogenesis Following Focal Cerebral Ischemia in Mice

[Transplantation of Gene-Transfected Neural Stem Cells for Transient Cerebral Ischemia in Rats].

Adeno-Associated Viral Vector-Mediated Hypoxia-Inducible Vascular Endothelial Growth Factor Gene Expression Attenuates Ischemic Brain Injury after Focal Cerebral Ischemia in Mice